TechnologyAI firms will face copyright infringement lawsuits in 2024 Tech giants are gearing up for a series of potentially bitter legal battles over claims they used copyrighted material in training the latest generation of artificial intelligence News
Health2023 saw a cautious hope for Alzheimer's treatment but doubts remain The US approved lecanemab to slow cognitive decline among people with early Alzheimer's, but not everyone is convinced the drug has that big of an impact – not to mention concerns over its safety and practicality News